<--- Back to Details
First PageDocument Content
Mitsubishi companies / Economy of Japan / Business / Economy / Mitsubishi / The Bank of Tokyo-Mitsubishi UFJ / UFJ / Mitsubishi Tanabe Pharma / Nikkei 225
Date: 2016-02-29 23:34:13
Mitsubishi companies
Economy of Japan
Business
Economy
Mitsubishi
The Bank of Tokyo-Mitsubishi UFJ
UFJ
Mitsubishi Tanabe Pharma
Nikkei 225

Contribution to Academic Study and Research for the Future     Index

Add to Reading List

Source URL: www.mitsubishi.com

Download Document from Source Website

File Size: 355,06 KB

Share Document on Facebook

Similar Documents

A Novel Descriptor Based on Atom-Pair Properties Masataka Kuroda Mitsubishi Tanabe Pharma Corporation  Descriptors can be classified into several groups. Property and fingerprint belong to zero and one dimensional descri

A Novel Descriptor Based on Atom-Pair Properties Masataka Kuroda Mitsubishi Tanabe Pharma Corporation Descriptors can be classified into several groups. Property and fingerprint belong to zero and one dimensional descri

DocID: 1sCFD - View Document

Contribution to Academic Study and Research for the Future      Index

Contribution to Academic Study and Research for the Future     Index

DocID: 1qT3z - View Document

EXHIBITION  FREE OF CHARGE: 1. Enjoy our free voice guide machine! (English, Chinese, Korean and Japanese)

EXHIBITION FREE OF CHARGE: 1. Enjoy our free voice guide machine! (English, Chinese, Korean and Japanese)

DocID: 1owUL - View Document

April 4, 2016 Press Release Mitsubishi Tanabe Pharma Corporation MT Pharma Singapore Pte. Ltd. Starts Business Operations Mitsubishi Tanabe Pharma’s Subsidiary in Singapore

April 4, 2016 Press Release Mitsubishi Tanabe Pharma Corporation MT Pharma Singapore Pte. Ltd. Starts Business Operations Mitsubishi Tanabe Pharma’s Subsidiary in Singapore

DocID: 1mvDN - View Document

December 21, 2015 Press release Mitsubishi Tanabe Pharma Corporation Remicade® for I.V. Infusion 100 Approval of Additional Indication for Kawasaki Disease

December 21, 2015 Press release Mitsubishi Tanabe Pharma Corporation Remicade® for I.V. Infusion 100 Approval of Additional Indication for Kawasaki Disease

DocID: 1mora - View Document